Exosomes DC-EX
Exosomes today represent a promising direction for the treatment, prevention, and rehabilitation of various diseases.

DC-EX exosomes have the therapeutic potential of mesenchymal stem cells, are easy to obtain, and can be stored for up to 2 years.

The fundamental basis for the therapeutic effects of DC-EX exosomes lies in their ability to transfer biological information—in the form of cytokines, peptides, and RNA—from stem cells to damaged cells.

DC-EX exosomes have theoretical advantages over intact MMSCs as a drug in the field of regenerative medicine.
Content
Our results
Total number of patients
details
Description of exosomes
Definition of exosomes. Functions, composition, and action of exosomes.
details
Use of exosomes
details
Comparison of exosomes and stem cells
details
Advantages of Exosomes DC-EX
details
Comparison of exosomes from bone marrow and umbilical cord MSCs
details
Key components of exosomes DC-EX
details
Types and packaging of exosomes DC-EX
details
Neuro exosomes DC-EX-NS
Specialized exosomes for treating central nervous system pathologies, mental and emotional fatigue, insomnia, and cognitive disorders.
details
Beauty exosomes DC-EX-BC
Pure, highly concentrated exosomes from bone marrow mesenchymal stem cells with increased content of growth factors and microRNA for regenerative cosmetology.
details
NK-cell-derived exosomes (NK-EX)
Pure, concentrated exosomes derived from NK cells from the peripheral blood of young, healthy donors, for the prevention and treatment of oncological diseases and infections.
details
Certificates
details
Our company
details
Treatment programs
details
Ask a question
details
Number of patients
Number of patients
Total number of our patients using exosomes for treatment and prevention
(data as of December 2025)
  • 1824
    TOTAL
  • 967
    Revitalization and treatment of diseases (intravenous)
  • 857
    Orthopedics and Cosmetology (local injections)
Exosomes
Description of exosomes
Exosomes are microscopic extracellular vesicles secreted into the intercellular space by cells of various tissues. Exosomes contain signaling substances that "tell" neighboring cells what and when to do.

Exosomes derived from human mesenchymal stem cells from bone marrow are the active ingredient in DC-Ex.

Exosomes provide:

• Epigenetic reprogramming (activates reparative cycle signaling pathways). Thus, cells reorient themselves toward the process of restoring the microenvironment.

• Exosomes also affect regional progenitor cells, triggering a cascade of migration and recruitment of other cellular elements and their differentiation. Microcirculation and cellular immunity are restored in tissues. Undesirable inflammatory reactions are blocked.
Exosomes consist of:
1. MicroRNA
2. Growth factors
3. Cytokines (signaling molecules)
4. Peptides
Exosome action:
1. Activation of regeneration
2. Reduction of inflammation, apoptosis (cell death), and fibrosis
3. Angiogenesis (growth of new capillaries)
4. Immunomodulation (stimulation or suppression)
Exosomes
Use of exosomes
1. Revitalization: increased performance; disease prevention; health maintenance; anti-aging therapy.
2. Treatment: diseases of the heart, lungs, brain and nervous system, liver, kidneys, autoimmune diseases, diabetes, infertility.
3. Orthopedics: joint and spine diseases, injuries.
4. Cosmetology: mesotherapy to slow down aging and promote healthy skin.
5. Urology: erectile dysfunction.
6. Dermatology: skin diseases.
7. Surgery: skin damage, burns, frostbite, purulent inflammation, etc.
8. Oncology
Exosomes
Comparison of exosomes with stem cells
The primary effect of donor stem cells is paracrine—that is, the expression of exosomes containing biologically active substances. Thus, donor stem cells exert their effects through exosomes. The use of exosomes from donor multipotent mesenchymal stem cells (MMSCs) can replace or complement the use of MMSCs.

In some cases, these effects have been clearly demonstrated to be as effective as the administration of whole-cell MMSCs. The fundamental basis for the therapeutic effects of exosomes lies in their ability to transfer biological information—in the form of proteins, glycoproteins, lipids, and ribonucleic acids—from stem cells to damaged cells.

Exosomes have theoretical advantages over intact MMSCs as a therapeutic agent and may in the future gain an advantage over whole cells in the field of regenerative medicine.

Exosomes are significantly less expensive than MMSCs. Unlike MMSCs, exosomes can be stored for a long time (up to 24 months).
Exosomes
Benefits of DC-EX exosomes
  • These are "true" exosomes – they contain CD-9 and CD-63 markers.
  • Ultra-high concentration of exosomes – up to 15 trillion per ml.
  • Large exosome size: 120-150 nm.
  • Homogeneity.
  • Infection safety.
  • Obtained from bone marrow mesenchymal stem cells, meaning they are safe (including for cancer) and highly effective.
  • Natural regeneration and control mechanisms.
  • High therapeutic activity.
  • Long shelf life (up to 2 years).
Exosomes DC-EX -
CD-9 affiliation marker
CD9 is a standard exosome marker recognized internationally. Detection of CD9 confirms that these are genuine exosomes.
Clinical significance: There are products on the market that are sold as "exosomes," but are actually:
  • conditioned medium
  • cellular debris
  • microparticles
Detection of CD9 proves that:
  • these are genuine extracellular vesicles
  • they are not protein supernatants
  • they are not an adulterated product
DC-EX exosomes are a marker of CD-63 affiliation.
CD63 is the second international exosome marker - detection of CD63 indicates compliance with standards.
Interpretation:
  • Only CD9 - possible impurities
  • Only CD63 - possible low concentrations
  • CD9 + CD63 - authentic, high-quality exosomes
Clinical conclusion:
  • Authentic material
  • Minimal impurities
  • Low risk of inflammation
  • High batch-to-batch stability
DC-EX Exosomes – Benefits of High Concentration
  1. Faster onset of anti-inflammatory effect
  2. Accelerated tissue repair
  3. Improved mitochondrial activity
  4. Simultaneous action on multiple symptoms (chronic inflammation, fatigue, nervous system, skin, liver, etc.)

The patient feels the effect even after a single treatment!

  • Most products on the market contain only 10-50 billion exosomes per ml, which is orders of magnitude less.
  • Changing the concentration directly impacts the clinical effect and patient satisfaction.
DC-EX Exosomes – The Benefits of Large Size
NanoSight Analysis (NTA)
The average size of DC-EX exosomes is 136.6 nm—closer to the upper limit (30–150 nm) and indicates a predominance of mature particles.

Advantages of mature particles:
  • contain many growth factors, cytokines, and microRNAs
  • better tissue repair
  • pronounced anti-inflammatory effect
  • high mitochondrial activity
DC-EX Exosomes – The Benefits of Homogeneity
Distribution: A single peak indicates minimal impurities.
If there were exosome contamination:
  • Several peaks
  • Broad tail
  • Size spread
Conclusion: DC-EX product:
  • Highly concentrated
  • Stable
  • Homogeneous

In a clinical setting, the following are important:
  • Concentration
  • Quality
  • Homogeneity
DC-EX Exosomes – Infection Safety
high level of infection safety
DC-EX exosomes -
comparison with umbilical cord exosomes
Disadvantages of umbilical cord exosomes
  • Increased OncomicroRNA
  • Risk of tumor stimulation
  • Immune hyperstimulation
  • Quality variability
Ethical and production risks
  • Risks for umbilical cord exosome clinics
  • Unpredictable results
  • Exacerbation of chronic diseases
  • Reputational risks
  • Legal risks
Clinical advantages of BM-MSCs
  • Better for chronic inflammation
  • Safer for autoimmune conditions
  • Suitable for anti-aging
  • Stable results
  • Natural mechanism – bone marrow-derived MSCs are programmed for regeneration and restoration. Accordingly, bone marrow-derived MSC exosomes are a natural regenerative mechanism created by nature. Adults lack umbilical cord MSCs.
  • Bone marrow-derived MSC exosomes have a perfectly balanced microRNA ratio: tumor suppressor microRNA ~78%; oncomicroRNA ~22%. This means an ideal balance of suppressive and stimulatory oncomicroRNAs. OncomiRs are essential, but their excess is dangerous. Therefore, bone marrow-derived exosomes carry no oncological risk.
Main components of
exosomes DC-EX - Growth Factors
DC-EX exosomes contain 60 growth factors (GFs). Key GFs and effects:
  • IGF/EGF/PDGF → tissue repair
  • VEGF → angiogenesis
  • HGF → liver repair
  • TGFβ → anti-inflammatory effect
  • IL-10 → anti-inflammatory effect
  • IL-1ra → immunoregulation

It's not "more is better"; it's the balance of GFs that matters. DC-ECGFs in exosomes are maximally balanced.

  • Injections of individual growth factors provide an isolated, rapid, and short-term effect.
  • Injections of DC-EX exosomes provide a combined, long-term effect.
Main components of
exosomes DC-EX – mRNA
Key areas of microRNA action:
  • Reproductive system
  • Inflammatory and immune diseases
  • Musculoskeletal system
  • Cardiovascular system
  • Nervous system
  • Metabolism
  • Skin and healing
Key benefits of microRNA DC-EX exosomes
  • High microRNA content against aging
  • Regulation of vascular inflammation
  • Suppression of cytokine excess
  • Safe oncoprofile (Tumor suppressor > OncomiR)
  • Affects multiple systems
  • High concentration and therapeutic value
MicroRNA balance in DC-EX exosomes
  • Tumor suppressor: ~78%
  • OncomiR: ~22%
→ perfect balance
DC-EX Exosome Composition:
  • Number of exosomes per ml: 5 to 15 trillion
  • Exosome size: 50-60 nm
  • Cytokines (signaling molecules)
  • 64 growth factors
  • Over 1000 microRNAs
Content of growth factors in DC-EX exosomes
Exosomes
Types and packaging of DC-EX exosomes:
  • DC-Ex-V- 10 ml – for intravenous use (anti-aging therapy, disease treatment, performance support). Exosome concentration: 15 trillion/ml (150 trillion in vial).
  • DC-Ex-L - 5 ml – for local injections (orthopedics, cosmetology, urology, surgery). Exosome concentration: 15 trillion/ml (75 trillion in vial).
  • DC-Ex-U – lyophilized powder with exosomes for intravenous and local injections. Must be diluted with saline before administration. Exosome concentration: 20 trillion/vial.
  • DC-Ex-N - 2 ml – drops for intranasal use (anti-aging therapy, disease treatment, performance support). Exosome concentration: 10 trillion/ml (20 trillion in vial)..
  • DC-Ex-S – 10 ml – spray for external use (cosmetology, dermatology, surgery). Exosome concentration: 7.5 trillion in vial.
  • DC-Ex-G – 15 ml – gel – for external use (dermatology, orthopedics, surgery). Exosome concentration: 7.5 trillion in vial.
EXOSOMES
Neuroexosomes DC-EX-NS
Pure, highly concentrated exosomes derived from bone marrow MSCs, enriched with neurotrophic growth factors and microRNAs.
GROWTH FACTORS
The following growth factors are considered the most important for the regeneration of the nervous system (brain, spinal cord, and peripheral nerves). They can be divided into several groups.
Neurotrophic factors (major)
1-NGF (Nerve Growth Factor)
  • One of the first neurotrophins to be discovered.
  • Supports neuronal survival.
  • Stimulates axon growth.
  • Particularly important for sensory and sympathetic neurons.
2-BDNF (Brain-Derived Neurotrophic Factor)
  • One of the most important factors in CNS recovery.
  • Improves neuronal survival.
  • Enhances neuroplasticity.
  • Promotes the formation of new synapses.
  • Improves memory and learning.
3-NT-3 (Neurotrophin-3)
  • Stimulates peripheral nerve regeneration.
  • Participates in spinal cord repair.
  • Supports myelination.
4-NT-4/5 (Neurotrophin-4/5)
  • Supports motor neurons.
  • Promotes the repair of nerve tissue following injury.
Insulin-like growth factors
IGF-1 (Insulin-like Growth Factor-1)
A crucial factor in nervous system recovery. Effects:
  • prevents neuronal death;
  • stimulates axon growth;
  • accelerates remyelination;
  • improves recovery after stroke;
  • promotes neurogenesis.
Vascular growth factors
VEGF (Vascular Endothelial Growth Factor)
In addition to blood vessel formation:
  • it protects neurons;
  • stimulates axon growth;
  • improves blood supply to damaged tissue;
  • promotes recovery after stroke and spinal cord injury.
FGF family factors
FGF-2 (Basic Fibroblast Growth Factor, bFGF)
  • stimulates the proliferation of neural stem cells;
  • promotes neurogenesis;
  • reduces neuronal death;
  • participates in recovery following brain injury.
Epidermal growth factors
EGF (Epidermal Growth Factor)
  • activates neural stem cells;
  • stimulates the formation of new neurons;
  • promotes the repair of brain tissue.
Glial growth factors
1-GDNF (Glial Cell Line-Derived Neurotrophic Factor)
One of the most potent neuroprotectors.
Particularly important for:
  • dopaminergic neurons;
  • motor neurons;
  • peripheral nerves.
It is being studied for:
  • Parkinson's disease;
  • ALS;
  • spinal cord injuries.
2-CNTF (Ciliary Neurotrophic Factor)
  • supports motor neurons;
  • stimulates peripheral nerve regeneration;
  • reduces neuronal degeneration.
3-HGF (Hepatocyte Growth Factor)
Despite its name:
  • it exhibits a pronounced neuroprotective effect;
  • reduces inflammation;
  • stimulates axon growth;
  • promotes recovery following cerebral ischemia.
4-PDGF (Platelet-Derived Growth Factor)
  • participates in glial repair;
  • promotes remyelination;
  • stimulates vascular regeneration.
5-TGF-β (Transforming Growth Factor beta)
  • regulates inflammation;
  • reduces secondary damage to nerve tissue;
  • participates in healing.
Micro-RNA
MicroRNAs (miRNAs) play a key role in nervous system repair by regulating the expression of hundreds of genes associated with neurogenesis, axon growth, remyelination, inflammation, and neuronal survival. They are being studied particularly intensively within the context of mesenchymal stem cell (MSC) exosomes.
The most extensively studied microRNAs are listed below.

MicroRNAs

Key effects

miR-124

Stimulates neuronal differentiation, reduces neuroinflammation, promotes recovery after stroke and spinal cord injury.

miR-133b

One of the best-known regulators of axon growth and neuroplasticity; it enhances recovery after stroke.

miR-21

Protects neurons from apoptosis, reduces inflammation, and promotes axon regeneration.

miR-17-92 (кластер)

Enhances neurogenesis, axon growth, and functional recovery.

miR-26a

Stimulates peripheral nerve regeneration and axon growth.

miR-146a

It suppresses microglial inflammatory responses and promotes neuroprotection.

miR-132

It participates in synapse formation, dendrite growth, and neuroplasticity.

miR-9

It regulates neuronal development and the formation of new nerve cells.

miR-219

One of the key regulators of oligodendrocyte maturation and remyelination.

miR-338

Promotes the restoration of myelin and oligodendrocyte function.

miR-210

Enhances angiogenesis and improves the recovery of brain tissue following ischemia.

miR-181c

It may reduce post-stroke damage through an anti-inflammatory effect (the role depends on the context).

miR-29b

Reduces fibrosis and supports neuronal survival and tissue repair.

miR-30d

It exhibits a neuroprotective effect and reduces apoptosis.

miR-125b

It participates in neuronal maturation; however, its overexpression can have adverse effects, so its action depends on the level and conditions.


Which microRNAs are considered the most important?
Based on the volume of experimental data and potential therapeutic significance, the following list can be identified:
1. miR-124 — neurogenesis and anti-inflammatory effect.
2. miR-133b — axon growth and neuroplasticity.
3. miR-21 — neuronal protection and regeneration.
4. miR-17-92 — axon and neuron repair.
5. miR-219 — remyelination.
6. miR-146a — inflammation control.
7. miR-132 — formation of new synapses.
8. miR-338 — myelin repair.
9. miR-26a — peripheral nerve regeneration.
10. miR-210 — angiogenesis and recovery from ischemia.

Many studies indicate that the therapeutic effect of exosomes is driven not by a single microRNA, but by a combination of them. A complex comprising miR-124, miR-133b, miR-21, miR-17-92, miR-146a, miR-219, and miR-338 is considered the most promising, as together they influence key processes of nervous tissue repair: reducing inflammation, protecting neurons, stimulating axon growth, enhancing neuroplasticity, and promoting remyelination.

DC-EX-NS neuroexosomes are engineered with an elevated concentration of neurotrophic growth factors (BDNF, NGF, GDNF, IGF-1, NT-3, FGF-2, VEGF, CNTF, HGF, EGF, PDGF, TGF-β) and microRNAs (miR-124, miR-133b, miR-21, miR-17-92, miR-146a, miR-219, and miR-338).
Exosomes
Beauty Exosomes DC-EX-BC
Pure, highly concentrated exosomes from bone marrow mesenchymal stem cells with increased content of growth factors and microRNA for regenerative cosmetology.
GROWTH FACTORS
In regenerative cosmetology, anti-aging products containing specialized growth factors can improve skin texture, reduce fine lines, enhance elasticity, and diminish pigmentation. It is not a single factor but rather a combination that is considered most important for regenerative cosmetology:

GROWTH FACTORS

The primary task regarding the skin

EGF

proliferation and migration of keratinocytes, epithelization

FGF-2 (bFGF)

fibroblast activation, dermal regeneration

KGF / FGF-7

epidermal regeneration, keratinocytes

PDGF-AA/BB

fibroblasts, ECM remodeling, healing

IGF-1

cell survival, matrix synthesis, regeneration

HGF

regeneration, cell migration, anti-inflammatory effect

VEGF-A

angiogenesis and microcirculation

TGF-β3

ECM remodeling and repair

TGF-β1

collagen synthesis



Micro-RNA
For regenerative cosmetology and anti-aging applications, a combination of miRNAs influencing the ECM, inflammation, and cellular senescence is of interest.

miRNA

Interest

miR-29b-3p

Photoaging, ECM, collagen remodeling

miR-29a-3p

ECM and fibrosis

miR-146a-5p

Inflammation, cellular senescence, collagen homeostasis

miR-126-3p

Angiogenesis and microcirculation

miR-126-5p

Endothelial function

miR-21-5p

Repair, cell migration

miR-1246

UVB/photoaging, collagen, anti-inflammatory activity

miR-125b-5p

Aging/differentiation

miR-130a/b

Angiogenesis and repair

miR-135a

ECM/fibroblast regulation

miR-181a

Inflammation and Aging

miR-210-3p

Hypoxia, angiogenesis, regeneration

miR-27a/b

Repair/angiogenic pathways

miR-31-5p

Migration and proliferation of keratinocytes

miR-221/222

Proliferation and vascular signaling


DC-EX-BC
It has a targeted biological profile, rather than simply aiming for the maximum concentration of individual molecules:
Growth factors:
FGF-2, EGF, KGF/FGF-7, HGF, IGF-1, PDGF-BB, along with controlled levels of VEGF and, in particular, TGF-β. EGF is supported by a substantial body of evidence regarding epithelial repair and aesthetic dermatology.
miRNA:
miR-29b-3p, miR-29a-3p, miR-146a-5p, miR-126-3p, miR-1246, miR-21-5p, miR-210-3p, and miR-130b-5p serve as regulated components of the natural exosomal cargo.
This profile simultaneously affects fibroblasts, collagen/elastin, the ECM, epidermal turnover, inflammation/photodamage, and microcirculation. This aligns with the primary mechanisms currently used to explain the effects of EVs/exosomes on skin rejuvenation.

DC-EX-BC exosomes increase collagen and elastin synthesis, reduce MMPs (matrix metalloproteinases) and oxidative stress, diminish wrinkles, and improve skin elasticity and hydration.



EXOSOMES
NK Exosomes NK-EX
Purified exosomes derived from NK cells of healthy donors for the treatment and prevention of cancer, tumors, and infectious diseases.
What are NK cells?
• NK cells are a type of white blood cell (leukocyte) that play a crucial role in the body’s immune system. They are involved in responding to atypical (cancerous) cells and certain foreign substances.
• NK cells function without the need for antibody stimulation or prior recognition of foreign substances, making them vital to the immune system.
Functions of NK cells:
• Rapid response: When foreign substances enter the body or atypical (cancerous) cells emerge, NK cells are activated and migrate to the area requiring defense. They immediately eliminate atypical cells, bacteria, and foreign substances through their exosomes.
• Interaction and coordination: NK cells transmit information about foreign agents and atypical (cancerous) cells to other immune cells via their exosomes, thereby supporting the integrated functioning of the immune system.
In this way, NK cells help maintain a balanced immune system and play a key role in responding to abnormal cells. They support overall health and immunity, ensuring the body is prepared to handle external threats.
NK-exosomes (NK-EX) are extracellular vesicles secreted by NK cells (natural killer cells).
They are of particular interest in oncology because they can carry components of the NK cell’s cytotoxic machinery, while not being living cells themselves.

Key components:
  • Cytotoxic proteins: perforin (PRF1), granzymes A and B (GZMA/GZMB), and granulysin (GNLY). These are involved in damaging target cells and triggering apoptosis within them.
  • Death-inducing molecules: FasL (CD95L) and TRAIL, which are capable of activating extrinsic apoptotic pathways in tumor cells.
  • Membrane proteins and extracellular vesicle (EV) markers: CD9, CD63, and CD81, as well as proteins associated with the NK-cell phenotype, including CD56 and (in certain preparations) NKG2D.
  • Regulatory proteins and enzymes: various signaling pathway proteins, adhesion molecules, and immunoregulatory components.
  • Nucleic acids: primarily microRNAs (miRNAs), as well as mRNAs and other non-coding RNAs. Examples include miR-186, miR-16, miR-23a, miR-155, and several others; the specific profile depends significantly on the state of the NK cells.
  • Lipids: cholesterol, sphingomyelin, phosphatidylserine, ceramides, and other membrane lipids characteristic of small extracellular vesicles.

Component

Main action

Perforin

Formation of pores in the target cell membrane

Granzyme B

Triggering apoptosis

Granzyme A

Cytotoxic effect

Granulysin

Cytolytic/antimicrobial activity

FasL (CD95L)

Activation of Fas-dependent apoptosis

TRAIL

Induction of apoptosis in tumor cells

miRNA

Regulation of gene expression in a target cell

CD56

Characteristic NK-associated marker

CD63, CD81, CD9

Typical EV/exosomal markers


Why they are of interest in oncology:
  • A key feature is their direct cytotoxic effect. NK-cell-derived exosomes can interact with tumor cells, enter them, and trigger apoptosis—notably via the perforin–granzyme system and death-receptor pathways.
  • Moreover, they offer a potential advantage over the administration of NK cells themselves: exosomes are significantly smaller than cells, do not proliferate, and are potentially easier to standardize as a biological product.

Types of NK exosomes:


NK-EX-1

NK-EX-5

NK-EX-10

Vial volume

10 ml

10 ml

10 ml

Number of exosomes in the vial

12 billions

60 billions

120 billions

Indication

Cancer prevention

Treatment of infections

Cancer treatment

Frequency of use

1 vial 1–3 times a year

1 vial once a week

1 vial 1–2 times a week

Course of treatment


1-2 weeks

2-4 weeks


Differences between NK exosomes and NK cells
  • Size. NK cells have a diameter of 10–15 µm, while NK exosomes are 200 times smaller, with a diameter of 30–150 nm. The volume of an NK cell is approximately 900 µm³, whereas an NK exosome is about 0.0009 µm³—a million times smaller. This disparity is one of the reasons why NK exosomes may penetrate tissues and cells more effectively.
  • Storage. Once they leave the laboratory, NK cells must be used within 24 hours—ideally, within 8 hours. They are highly sensitive to transport conditions and perish easily if these conditions are not strictly maintained. NK exosomes, by contrast, can be stored in a deep-frozen or lyophilized state for up to 2 years (at -80°C); they remain viable for 3 months when frozen (-20°C), for 1 week when refrigerated (+8°C), and for 24 hours at room temperature. Consequently, NK exosomes are much easier to transport and store.
  • Exosomes as the primary tool of cells. NK cells carry out their core function—the destruction of target cells (such as cancer cells, foreign cells, or bacteria)—by utilizing NK exosomes. Furthermore, NK cell-derived exosomes facilitate communication with the body’s immune system. Therefore, by administering purified NK exosomes, we achieve the same functional outcome.
The main potential advantage of NK-cell-derived exosomes (NK-EX) over the administration of NK cells themselves is the ability to deliver a portion of their cytotoxic "arsenal" without introducing living cells.

Parameter

NK-cells

NK-EX

Direct destruction of the target cell

Very strong

Strong

Perforin, granzymes

+++

++

FasL / TRAIL

+++

+/++

Cell viability is required

Yes

No

Dependence on the immunosuppressive tumor microenvironment

High

Low

Penetration into the dense tissue of a tumor

Limited

High

Storage and standardization

Difficult, 24 hours, instability

Simple, 2 years, stability

The risk of uncontrolled behavior in living cells

Yes

No


What is particularly interesting about NK-cell-derived exosomes (NK-exosomes) is the following:
  • NK-exosomes can contain perforin, granzymes A/B, FasL, and TRAIL, as well as various cytotoxic and immunoregulatory miRNAs. Once taken up by a tumor cell, this cargo can trigger apoptosis.
  • There is another potentially significant distinction. A living NK cell must reach the tumor, maintain its activity, recognize its target, and form an immunological synapse. The tumor microenvironment, however, can suppress NK cells through factors such as TGF-β, hypoxia, adenosine, and other mechanisms. An exosome, by contrast, does not need to maintain cellular metabolism or form a full-fledged immunological synapse.
  • Furthermore, due to their size—ranging from tens to hundreds of nanometers—NK-exosomes are considered a potentially more effective means of penetrating certain dense tumor tissues and delivering active molecules.

NK-EX – key advantages:
1. NK-EX – exosomes derived from donor cells.
The difference lies in MHC-I receptors. When a patient’s cancer cells express MHC-I molecules that inhibit the patient’s own NK cells, donor-derived NK-EX—which carry different MHC-I alleles (gene variants that determine the structure of MHC-I molecules)—are not subject to this inhibition. Consequently, this leads to a more effective elimination of the patient’s cancer cells.
2. NK-EX are produced from a donor’s peripheral blood, rather than from umbilical cord blood.
  • These NK cells are inherently more mature. Comparative studies have shown that resting NK cells from umbilical cord blood exhibit lower cytotoxic activity than those from adult peripheral blood.
  • NK-derived exosomes from adult donors contain a higher concentration of cytotoxic proteins and demonstrate greater activity compared to those derived from umbilical cord blood.
  • It is possible to use the same donor multiple times—an option not available with umbilical cord blood. This facilitates the production of batches from a single source, allowing for the assessment of property consistency.
  • Donors and cultures can be selected based on their actual activity levels; for instance, the cytotoxicity of NK cells can be evaluated prior to vesicle collection. Ultimately, however, the activity of the purified vesicles themselves remains the decisive factor.
  • It is well established that NK cells from adult peripheral blood differ significantly from those found in umbilical cord blood. While the formation of NK-cell-derived exosomes is not yet fully understood, a simplified model suggests that these exosomes inherit most of the properties of their parent cells. Consequently, NK-cell-derived exosomes largely reflect the characteristics of the specific NK cells from which they originate.
  • What are the specific advantages of using exosomes derived from an adult donor’s peripheral blood NK cells—as opposed to those from umbilical cord blood—for anti-tumor therapy? It has long been established that adult NK cells exhibit superior degranulation, mount a more potent attack against tumor cells, and are more effective at controlling tumors.
(doi.org/10.1182/bloodadvances.2019000835, doi.org/10.1111/j.1474-9726.2010.00584.x)Wang Y, Xu H, Zheng X, Wei H, Sun R, Tian Z. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol. 2007 Oct;4(5):377-82. PMID: 17976318.).

  • For antitumor therapy using whole cells, such "excess" activity can be a negative trait, as it shifts the balance between safety and efficacy; however, for exosomes, safety concerns are less significant, given that exosomes are inherently safer than whole cells and cannot proliferate within the patient's body. NK cells derived from adult blood are more readily activated in response to cytokine exposure (10.1016/j.jcyt.2014.08.003), which suggests the potential for a more potent exosome-based therapeutic agent. Another characteristic of NK cells derived from umbilical cord blood is their lower expression of adhesion receptors.
(doi.org/10.1034/j.1600-0609.2003.00081.x).
  • Трафик экзосом NK-клеток взрослой крови обладает более благоприятным профилем.
Thus, unlike cell-based products—where excessive activity can be associated with undue toxicity—there is no such thing as "too much" activity when it comes to exosomes. For this reason, exosomes derived from the peripheral blood NK cells of adults are more suitable for anti-tumor therapy.

NK-EX are important components of the body's immune system.
What changes can occur in the body when the function of NK cells is altered?
  • Increased physical weakness, manifesting as fatigue, lethargy, and a need for more sleep to achieve full recovery.
  • More frequent infections than usual, such as herpes, shingles, hepatitis, and common colds.
  • A higher risk of developing cancer.
A weakened immune system can result from stress, an unbalanced diet, a poor environment, and an unhealthy lifestyle (physical inactivity, smoking, alcohol consumption, staying up at night, failure to follow hygiene practices, etc.).

The best defense begins with a balanced immune system.
  • Good health is more than just the absence of disease; it involves preparing the body from within to ensure a high quality of life in the long term.
  • Preventive care is an ideal choice for a modern lifestyle. NK-cell (natural killer cell) therapy is an approach designed to enhance cellular function and strengthen the immune system, helping to maintain its balance.
  • The procedure is performed by a team of specialists at our clinics.

Key features of NK-cell therapy:
  • Immune support: enhancing the effectiveness of the body’s natural immune system.
  • Identification and control of abnormal cells: assisting in the detection of abnormal cells within the body.
  • Internal balance: a focus on comprehensive health restoration and strengthening.
  • Personalized approach: treatment plans are developed by a team of experienced physicians, tailored to your body’s individual needs.
  • Suitable for those who care about their health, seek to strengthen their immune system, and prioritize disease prevention.
Exosomes
Certificates:
DOKAR VITA CELLS COMPANY
About company
Dokar Vita Cells — an international company whose main activities are:

1. Organization and oversight of the production of cellular products (allogeneic multipotent mesenchymal stem cells from bone marrow (BM-MMSCs), DC-Ex exosomes, NK cells, oncolytic viruses, etc.) in our own and partner laboratories.
2. Organization of treatment with cellular products (BM-MMSCs, exosomes, NK cells, oncolytic viruses) in partner clinics in Russia, Europe, Thailand, and Vietnam.
3. Organization of training for physicians in cellular technologies.
DOKAR VITA CELLS COMPANY
LAB-1
Closed research laboratory of cellular technologies.

• Production of cell cultures from human bone marrow and umbilical cord blood
• Production of allogeneic NK cells
• Research activities
• Experimental activities
DOKAR VITA CELLS COMPANY
LAB-3
Private research laboratory of cellular technologies.

•Production of cell cultures from bone marrow
•Research activities
•Experimental activities
DOKAR VITA CELLS COMPANY
Exosome production

There are three main methods for producing exosomes:

  • Differential ultracentrifugation (DUC)
  • Density gradient ultracentrifugation
  • Ultrafiltration

We use our own ultrafiltration method.

During the MMSC cultivation process, exosomes are isolated into a nutrient medium. After MMSC isolation, a solution containing exosomes (supernatant) remains in the cultivation chamber.

The supernatant is then filtered and concentrated (5 or 10 times), and packaged.

DOKAR Laboratory has developed its own exosome production technology—triple filtration and concentration.

We use 0.22 and 0.45 µm filters and dialysis cartridges.

We have created our own exosome concentration system.

Use of exosomes
Treatment programs with exosomes
Program 1 - Revitalization
Program 2 - Treatment
Program 3 - Orthopedics
Program 4 - Cosmetology
Program 5 - Urology
Program 6 - Dermatology
Program 7 - Surgery
Program 8 - Sports
Your question
Just write your question and we will answer as soon as possible.
Consent to the processing of personal data
I agree to the processing of my personal data in accordance with the privacy policy.

DC-EX ORDER

To order DC-EX exosomal products, please text us to email: dokartest@gmail.com


Text to us
dokartest@gmail.com
Made on
Tilda